PubRank

Theoharis C Theoharides

Author PubWeight™ 92.45‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Mast Cells, Mastocytosis, and Related Disorders. N Engl J Med 2015 3.90
2 Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine. Mayo Clin Proc 2002 2.67
3 Key role of CRF in the skin stress response system. Endocr Rev 2013 1.77
4 IL-10, an inflammatory/inhibitory cytokine, but not always. Immunol Lett 2003 1.76
5 Neuroimmunology of stress: skin takes center stage. J Invest Dermatol 2006 1.72
6 The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis. Urology 2007 1.67
7 Neuroimmunoendocrine circuitry of the 'brain-skin connection'. Trends Immunol 2005 1.58
8 High levels of intrauterine corticotropin-releasing hormone, urocortin, tryptase, and interleukin-8 in spontaneous abortions. Endocrinology 2003 1.52
9 Corticotropin-releasing hormone-receptor 2 is required for acute stress-induced bladder vascular permeability and release of vascular endothelial growth factor. BJU Int 2010 1.46
10 Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells. Br J Pharmacol 2005 1.45
11 Acute stress induces cardiac mast cell activation and histamine release, effects that are increased in Apolipoprotein E knockout mice. Cardiovasc Res 2002 1.45
12 Acute stress-induced seizures and loss of consciousness in a ten-year-old boy with cutaneous mastocytosis. J Clin Psychopharmacol 2002 1.45
13 Chronic fatigue syndrome, mast cells, and tricyclic antidepressants. J Clin Psychopharmacol 2005 1.44
14 Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor. J Immunol 2005 1.31
15 Corticotropin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress. J Pharmacol Exp Ther 2002 1.23
16 Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells. Endocrinology 2003 1.14
17 Brain cytokines and neuropsychiatric disorders. J Clin Psychopharmacol 2004 1.14
18 IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells. J Immunol 2003 1.11
19 Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process. Proc Natl Acad Sci U S A 2006 1.10
20 Serotonin-selective reuptake inhibitors and nonsteroidal anti-inflammatory drugs--important considerations of adverse interactions especially for the treatment of myalgic encephalomyelitis/chronic fatigue syndrome. J Clin Psychopharmacol 2011 1.09
21 Spectrum of mast cell activation disorders. Expert Rev Clin Immunol 2014 1.08
22 Advances in therapy with antileukotriene drugs. Ann Clin Lab Sci 2004 1.07
23 Mast cell tryptase: a new biomarker in patients with stable coronary artery disease. Atherosclerosis 2005 1.05
24 Mitochondrial DNA and anti-mitochondrial antibodies in serum of autistic children. J Neuroinflammation 2010 1.04
25 Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells. J Invest Dermatol 2011 1.03
26 Human mast cell degranulation and preformed TNF secretion require mitochondrial translocation to exocytosis sites: relevance to atopic dermatitis. J Allergy Clin Immunol 2011 1.02
27 Role of mast cells in tumor growth. Ann Clin Lab Sci 2007 1.01
28 Neurotensin is increased in serum of young children with autistic disorder. J Neuroinflammation 2010 1.01
29 Mast cells in allergic and inflammatory diseases. Curr Pharm Des 2012 0.95
30 Effect of stress on brain inflammation and multiple sclerosis. Autoimmun Rev 2013 0.95
31 Corticotropin-releasing hormone induces vascular endothelial growth factor release from human mast cells via the cAMP/protein kinase A/p38 mitogen-activated protein kinase pathway. Mol Pharmacol 2005 0.94
32 Mercury induces inflammatory mediator release from human mast cells. J Neuroinflammation 2010 0.94
33 Perinatal stress, brain inflammation and risk of autism-review and proposal. BMC Pediatr 2012 0.94
34 Skin corticotropin-releasing hormone receptor expression in psoriasis. J Invest Dermatol 2007 0.92
35 Regulation of IL-1-induced selective IL-6 release from human mast cells and inhibition by quercetin. Br J Pharmacol 2006 0.90
36 Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans. PLoS One 2012 0.90
37 Use of polyphenols in periodontal inflammation. Eur J Pharmacol 2013 0.89
38 Stimulated human mast cells secrete mitochondrial components that have autocrine and paracrine inflammatory actions. PLoS One 2012 0.88
39 IL-9 induces VEGF secretion from human mast cells and IL-9/IL-9 receptor genes are overexpressed in atopic dermatitis. PLoS One 2012 0.88
40 Niacin-induced "flush" involves release of prostaglandin D2 from mast cells and serotonin from platelets: evidence from human cells in vitro and an animal model. J Pharmacol Exp Ther 2008 0.88
41 Mitochondria distinguish granule-stored from de novo synthesized tumor necrosis factor secretion in human mast cells. Int Arch Allergy Immunol 2012 0.88
42 IL-32 is increased along with tryptase in lesional psoriatic skin and is up-regulated by substance P in human mast cells. Eur J Dermatol 2010 0.88
43 Stress-induced interleukin-6 release in mice is mast cell-dependent and more pronounced in Apolipoprotein E knockout mice. Cardiovasc Res 2003 0.87
44 Interleukin-16 network in inflammation and allergy. Allergy Asthma Proc 2002 0.87
45 Flavones inhibit proliferation and increase mediator content in human leukemic mast cells (HMC-1). Eur J Haematol 2003 0.87
46 Increased numbers of activated mast cells in endometriosis lesions positive for corticotropin-releasing hormone and urocortin. Am J Reprod Immunol 2004 0.87
47 Mitochondrial uncoupling protein 2 inhibits mast cell activation and reduces histamine content. J Immunol 2009 0.86
48 Autism spectrum disorders and mastocytosis. Int J Immunopathol Pharmacol 2010 0.86
49 Coronary stents, hypersensitivity reactions, and the Kounis syndrome. J Interv Cardiol 2007 0.85
50 Azelastine inhibits secretion of IL-6, TNF-alpha and IL-8 as well as NF-kappaB activation and intracellular calcium ion levels in normal human mast cells. Int Arch Allergy Immunol 2003 0.84
51 Urocortin induces interleukin-6 release from rat cardiomyocytes through p38 MAP kinase, ERK and NF-kappaB activation. J Mol Endocrinol 2009 0.84
52 Brief report: "allergic symptoms" in children with Autism Spectrum Disorders. More than meets the eye? J Autism Dev Disord 2011 0.83
53 Interleukin-17 and the interleukin-17 family member network. Allergy Asthma Proc 2004 0.83
54 Corticotropin-releasing hormone receptor-1 and histidine decarboxylase expression in chronic urticaria. J Invest Dermatol 2005 0.82
55 Stress-induced dura vascular permeability does not develop in mast cell-deficient and neurokinin-1 receptor knockout mice. Brain Res 2003 0.82
56 Neurotensin and CRH interactions augment human mast cell activation. PLoS One 2012 0.82
57 Interleukin-6 and mast cells. Allergy Asthma Proc 2002 0.82
58 Acute stress results in skin corticotropin-releasing hormone secretion, mast cell activation and vascular permeability, an effect mimicked by intradermal corticotropin-releasing hormone and inhibited by histamine-1 receptor antagonists. Int Arch Allergy Immunol 2003 0.82
59 Neuroendocrine-immune disequilibrium and endometriosis: an interdisciplinary approach. Semin Immunopathol 2007 0.81
60 Nasal provocation of patients with allergic rhinitis and the hypothalamic-pituitary-adrenal axis. Ann Allergy Asthma Immunol 2007 0.81
61 Interleukin-8 is increased in gingival crevicular fluid from patients with acute pulpitis. J Endod 2008 0.81
62 Autism, gut-blood-brain barrier, and mast cells. J Clin Psychopharmacol 2008 0.81
63 Increased affected skin gene expression and serum levels of thymic stromal lymphopoietin in atopic dermatitis. Ann Allergy Asthma Immunol 2010 0.81
64 Azelastine is more potent than olopatadine n inhibiting interleukin-6 and tryptase release from human umbilical cord blood-derived cultured mast cells. Ann Allergy Asthma Immunol 2002 0.81
65 Regulation of corticotropin-releasing hormone receptor-2 expression in human cord blood-derived cultured mast cells. J Mol Endocrinol 2005 0.80
66 Decreased mitochondrial function and increased brain inflammation in bipolar disorder and other neuropsychiatric diseases. J Clin Psychopharmacol 2011 0.80
67 Corticotropin-releasing hormone and extracellular mitochondria augment IgE-stimulated human mast-cell vascular endothelial growth factor release, which is inhibited by luteolin. J Neuroinflammation 2012 0.80
68 When to suspect interstitial cystitis. J Fam Pract 2011 0.80
69 Stimulation of CCL2 (MCP-1) and CCL2 mRNA by substance P in LAD2 human mast cells. Transl Res 2009 0.80
70 Atopic conditions in search of pathogenesis and therapy. Clin Ther 2013 0.80
71 Increased serum CRH levels with decreased skin CRHR-1 gene expression in psoriasis and atopic dermatitis. J Allergy Clin Immunol 2012 0.80
72 Environmental and occupational stress and autoimmunity. Autoimmun Rev 2008 0.80
73 Lack of c-kit receptor promotes mammary tumors in N-nitrosomethylurea-treated Ws/Ws rats. Cancer Cell Int 2008 0.79
74 Perifollicular and perivascular mouse skin mast cells express corticotropin-releasing hormone receptor. J Invest Dermatol 2006 0.79
75 Panic disorder, interstitial cystitis, and mast cells. J Clin Psychopharmacol 2004 0.79
76 Rupatadine inhibits proinflammatory mediator secretion from human mast cells triggered by different stimuli. Int Arch Allergy Immunol 2009 0.79
77 Inhibitory effect of quercetin on tryptase and MCP-1 chemokine release, and histidine decarboxylase mRNA transcription by human mast cell-1 cell line. Neuroimmunomodulation 2006 0.78
78 Secondary anetoderma associated with mastocytosis. Int Arch Allergy Immunol 2006 0.78
79 Amitriptyline and prochlorperazine inhibit proinflammatory mediator release from human mast cells: possible relevance to chronic fatigue syndrome. J Clin Psychopharmacol 2011 0.78
80 The effect of a herbal water-extract on histamine release from mast cells and on allergic asthma. J Herb Pharmacother 2003 0.78
81 Alzheimer patients treated with an AchE inhibitor show higher IL-4 and lower IL-1 beta levels and expression in peripheral blood mononuclear cells. J Clin Psychopharmacol 2004 0.78
82 The isoflavone genistein inhibits proliferation and increases histamine content in human leukemic mast cells. Allergy Asthma Proc 2003 0.77
83 Brain metastases of mouse mammary adenocarcinoma is increased by acute stress. Brain Res 2010 0.77
84 Mast Cells, Mastocytosis, and Related Disorders. N Engl J Med 2015 0.77
85 Corticotropin-releasing factor (CRF) can directly affect brain microvessel endothelial cells. Brain Res 2003 0.77
86 Mast cells and stress--a psychoneuroimmunological perspective. J Clin Psychopharmacol 2002 0.77
87 Response of spinal myoclonus to a combination therapy of autogenic training and biofeedback. Biopsychosoc Med 2007 0.77
88 Irritable bowel syndrome and the elusive mast cells. Am J Gastroenterol 2012 0.77
89 Azelastine's inhibition of histamine and tryptase release from human umbilical cord blood-derived cultured mast cells as well as rat skin mast cell-induced vascular permeability: comparison with olopatadine. Allergy Asthma Proc 2002 0.76
90 Pentosanpolysulfate (Elmiron) is a potent inhibitor of mast cell histamine secretion. Adv Exp Med Biol 2003 0.76
91 Unwanted interactions among psychotropic drugs and other treatments for autism spectrum disorders. J Clin Psychopharmacol 2012 0.76
92 Relation of serum levels of mast cell tryptase of left ventricular systolic function, left ventricular volume or congestive heart failure. J Card Fail 2004 0.76
93 Rupatadine inhibits inflammatory mediator release from human laboratory of allergic diseases 2 cultured mast cells stimulated by platelet-activating factor. Ann Allergy Asthma Immunol 2013 0.75
94 Depressive symptoms in urticaria patients treated with first- or second-generation histamine 1 receptor antagonists. J Clin Psychopharmacol 2007 0.75
95 Recent insights in primary immunodeficiency diseases: the role of T-lymphocytes and innate immunity. Ann Clin Lab Sci 2010 0.75
96 Antidepressants and risk of cancer: a case of misguided associations and priorities. J Clin Psychopharmacol 2003 0.75
97 Theophylline as 'add-on' therapy to cetirizine in patients with chronic idiopathic urticaria. A randomized, double-blind, placebo-controlled pilot study. Int Arch Allergy Immunol 2006 0.75